STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS
Clinical trial NCT04635631 · COMPLETED
Trial details
- NCT number
- NCT04635631
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-08-08
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.